Literature DB >> 10465735

Characterization of solute binding at human serum albumin site II and its geometry using a biochromatographic approach.

E Peyrin1, Y C Guillaume, C Guinchard.   

Abstract

Chiral recognition mechanism relationships for binding at site II on human serum albumin (HSA) were investigated using D, L dansyl amino acids. Sodium phosphate salt was used as a solute-HSA interaction modifier. A new model was developed using a biochromatographic approach to describe the variation in the transfer equilibrium constant with the salt concentration, i.e., the nature of the interactions. The solute binding was divided into two salt concentration ranges c. For the low c values, below 0.03 M, the nonstereoselective interactions constituted the preponderant contribution to the variation in the solute binding with the salt concentration. For the high c values, above 0.03 M, the solute binding was governed by the hydrophobic effect and the stereoselective interactions. The different contributions implied in the binding process provided an estimation of both the surface charge density (sigma/F) and the surface area of the site II binding cavity accessible to solvent, which were found to be equal to around 10.10(-7) mol/m(2) and 2 nm(2). As well, the excess of sodium ions excluded by the solute transfer from the surface area of the pocket were about(-0.7) for dansyl norvaline and (-0.8) for dansyl tryptophan.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465735      PMCID: PMC1300412          DOI: 10.1016/S0006-3495(99)76972-9

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  30 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

3.  Pressure-induced retention variations in reversed-phase alternate-pumping recycle chromatography.

Authors:  K Lan; J W Jorgenson
Journal:  Anal Chem       Date:  1998-07-15       Impact factor: 6.986

4.  Interactions between dansyl amino acids and human serum albumin using high-performance liquid chromatography: mobile-phase pH and temperature considerations.

Authors:  E Peyrin; Y C Guillaume; C Guinchard
Journal:  Anal Chem       Date:  1997-12-15       Impact factor: 6.986

5.  Peculiarities of dansyl amino acid enantioselectivity using human serum albumin as a chiral selector.

Authors:  E Peyrin; Y C Guillaume; C Guinchard
Journal:  J Chromatogr Sci       Date:  1998-02       Impact factor: 1.618

Review 6.  The location of drug binding sites in human serum albumin.

Authors:  K J Fehske; W E Müller; U Wollert
Journal:  Biochem Pharmacol       Date:  1981-04-01       Impact factor: 5.858

7.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

8.  Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography.

Authors:  A Chattopadhyay; T Tian; L Kortum; D S Hage
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-09-11

9.  Increased thermal stability of proteins in the presence of sugars and polyols.

Authors:  J F Back; D Oakenfull; M B Smith
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

10.  Structural requirements for drug binding to site II on human serum albumin.

Authors:  S Wanwimolruk; D J Birkett; P M Brooks
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

View more
  1 in total

1.  The Bcl-2 antagonist HA14-1 forms a fluorescent albumin complex that can be mistaken for several oxidized ROS probes.

Authors:  David Kessel; Michael Price; John J Reiners
Journal:  Photochem Photobiol       Date:  2008-05-29       Impact factor: 3.421

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.